Includes bibliographical references (p. 238-242) and index.
|Other titles||Biotechnology & patent law|
|Statement||N.S. Sreenivasulu, C.B. Raju.|
|Contributions||Raju, C. B.|
|The Physical Object|
|Pagination||xiv, 249 p. ;|
|Number of Pages||249|
|LC Control Number||2008336837|
Aaron Fellmeth, Dennis S. Karjala Professor of Law, Science, and Technology, Sandra Day O'Connor College of Law This book provides an approachable overview of three complicated areas of law that are relevant to biotechnology: patent law, regulatory approval for . The book provides a solid overview of patent law in the major markets, with emphasis on pharmaceutical, chemical and biotechhnology patents. What distinguishes this book from others in its class, however, is the emphasis on practical and strategic aspects of patent filing and by: Patent Expert Issues: Biotechnology Biotechnology generally concerns the application of cellular and molecular biology to make or modify products or processes. It includes scientific and industrial disciplines focused on understanding and manipulating living or biologically-active material at the molecular level, often involving DNA techniques. Recently cited by the United States Supreme Court in Nautilus, Inc. v. Biosig Instruments, Inc., this book is a concise reference that collects caselaw dealing with every aspect of patent claim construction by the Federal Circuit.. Book $ $
U.S. Biotechnology Patent Law, , authored by firm director Jorge A. Goldstein, Ph.D., is an update to the third book is a highly readable and well-organized desktop companion for practicing attorneys, and patent agents, seeking effortless entry into U.S. case law dealing with patents in modern biotechnology. U.S. Biotechnology Patent Law is a highly readable and well-organized desktop companion for practicing attorneys, and patent agents, seeking effortless entry into U.S. caselaw dealing with patents in modern biotechnology. Using the book's descriptive subtitles or its double-entry tables, experienced or novice prosecutors, litigators, inside counsel or academicians can readily access any sub. This course emphasizes patent law principles and doctrines as applied to biotechnology, including pharmaceutical, patents. Although there will be some coverage of United States Patent and Trademark Office policies as well as biotechnology patent principles in non-U.S. jurisdictions, the focus will be on U.S. Federal Circuit and Supreme Court case law developments. Meanwhile, there was a shortage of people qualified, in science and in law, to work in patent law, and in the biotech industry the need for new patent expertise was -- and is -- increasing.
In the context of examining and analyzing the legal and social implications arising from the recent conjunction of biotechnology and intellectual property rights, the book particularly focuses on human genes and gene variations. Emphasis is placed on “patent law,” as a considerable percentage of genetic inventions are covered by : Springer India. Updated by Cheryl Nyberg () and law librarianship intern Joe Cera (). This guide identifies print and online resources on legal issues affecting the biotechnology industry. Book titles are linked to records in the Gallagher Law Library catalog so that users can tell whether a particular book is available. The Law and Strategy of Biotechnology Patents is a compendium of articles that sets to address and unravel the complexities of the laws and issues that apply to biotechnology inventions. The purpose of the book is to explain patent law, with special emphasis on the central role of patent claims, statutory subject matter, novelty, non. These issues still continue to haunt the Biotechnology Patent Law and this paper gives an overview of the laws in the European Union, India, China, Australia, USA and the TRIPs regime itself. Also, dealt herewith are specific issues relating to patentability of life forms which need to address in context of the world scenario.